Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of transdermal buprenorphine (Transtec) versus gabapentin (Neurontin) for neuropathic pain
2005-001165-33Phase 4Completed
- Sponsor
- Bart Morlion
- Start
- Dec 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Neuralgia comparing Transdermal buprenorphine (Transtec) with Gabapentin (Neurontin) (2 arms). Primary endpoints: Efficacy comparison between Transtec and Neurontin and Safety comparison between Transtec and Neurontin. Started Dec 2005; status: completed.
02
Drugs
buprenorphinegabapentin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2005-001165-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001165-33.